PANBELA THERAPEUTICS ANNOUNCES $5.0 MILLION BOUGHT DEAL OFFERING OF COMMON STOCK
MINNEAPOLIS, June 29, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA) (the Company or Panbela), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced that…
